March 31, 2025 |
OPEN Health Group is pleased to announce the appointment of Matt D’Auria as its new Chief Executive Officer (CEO). Based in the US, Matt brings more than 25 years of experience in medical affairs and scientific commercialization to his new role, where he will focus on refining and deploying an innovation and growth strategy.

March 31, 2025, London, UK – OPEN Health Group is pleased to announce the appointment of Matt D’Auria as its new Chief Executive Officer (CEO). Based in the US, Matt brings more than 25 years of experience in medical affairs and scientific commercialization to his new role, where he will focus on refining and deploying an innovation and growth strategy.
Before joining OPEN Health, he served as CEO of the Healthcare Consultancy Group (HCG), a medical communications business within Omnicom. During his tenure, he led enterprise client partnerships, expanded global teams, and developed market access strategies that helped drive consistent growth. Matt has also held agency leadership roles at Envision Communications and Syneos Health, and he cites a diverse set of oncology marketing and sales roles at AstraZeneca for shaping his approach to scientific commercialization.
“I am truly honored to lead OPEN Health at this time,” said Matt. “We have an incredible team, a strong foundation, and an unwavering commitment to providing services that play an important role in the translation of scientific complexity into clinical meaning, bringing medicine closer to patients in need.”
“Matt’s global experience, commitment to scientific excellence, and innovation mindset align perfectly with OPEN Health’s core values and growth strategy,” said Dave King, Chairman of OPEN Health’s Board of Directors. “We are confident that he will lead us to even greater heights, and we are excited for the future under his leadership.”
Matt succeeds Vivid Sehgal, Interim CEO, who will continue his journey with OPEN Health by joining the company’s board as a Non-Executive Director.
About OPEN Health
OPEN Health unites deep scientific knowledge with wide-ranging specialist expertise to unlock possibilities that improve health outcomes and patient well-being. Working in partnership with our clients, we embrace our different perspectives and strengths to deliver fresh thinking and solutions that make a difference. OPEN Health is a flexible global organization that solves complex healthcare challenges across consulting, HEOR and market access, scientific communications, patient engagement, and creative omnichannel communications. To learn more, visit www.openhealthgroup.com
Contact:
Candice Subero, VP of Global Marketing
This content was provided by OPEN Health
Company Details
Latest Content from OPEN Health
We asked Mina Patel to give us an insight into her role as Global Head of Publications at OPEN Health
Explore more with OPEN Health
Join OPEN Health and Pharmerit – an OPEN Health Company at the World Orphan Drug Virtual Congress from August 24-27, 2020, as we present:Advanced Therapies Commercial: Tuesday, August 25Succeeding with Star Wars...
Our Director of Rare Disease, Gavin Jones looks forward to his conversation with Emily Crossle & Betsy Bogard at #WODCUSA2020 !
We are delighted to announce that OPEN Health Medical Communications was named Medical Affairs Agency of the Year at the virtual 2020 Communiqué Awards ceremony on 02 July 2020.
Ditch the Label – it’s just me.
OPEN Health is pleased to announce that Candice Subero has been named Global Marketing Lead, effective June 4, 2020. Candice will oversee strategic communications and marketing efforts across all OPEN...
OPEN Health are proud to support RARE Revolution Magazine who have launched a dedicated RARE youth online platform powering up the voices of the youth rare disease community.
OPEN Health, the family of expert practices working in partnership to drive positive change in healthcare communications and market access, has appointed Jeff Anderson as European Lead for the combined...
Summary of their recently published white paper on gene therapy followed by a Q&A session on 12th June 2020. Book now!
